NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
William L. Redmond
Providence Health & Services - Renton / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4981275
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
William L. Redmond's MOST POPULAR ARTICLES
1-)
Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape LA Emens, PA Ascierto, PK Darcy, S Demaria, AMM Eggermont, ... European journal of cancer 81, 116-129, 2017 4772017
2-)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ...The Lancet Oncology 19 (5), 694-704, 20183812018
3-)
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancerJN Graff, JJ Alumkal, CG Drake, GV Thomas, WL Redmond, M Farhad, ...Oncotarget, 20163812016
4-)
Peripheral tolerance of CD8 T lymphocytesWL Redmond, LA ShermanImmunity 22 (3), 275-284, 20053362005
5-)
OX40 agonists and combination immunotherapy: putting the pedal to the metalSN Linch, MJ McNamara, WL RedmondFrontiers in oncology 5, 34, 20152972015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept